Author: Kathy Whitney
Sep. 24, 2015—Vanderbilt is embarking on a multi-disciplinary approach to understand how promising cancer treatments, specifically certain kinase inhibitors, affect the heart and kidneys.
Sep. 17, 2015—The initial results of a landmark clinical trial sponsored by the National Institutes of Health (NIH) indicate lowering systolic blood pressure below a commonly recommended target significantly reduces rates of cardiovascular events and lowers risk of death in a group of adults 50 years and older.
Sep. 17, 2015—In April 1986 Bonnie Davis of Mt. Pleasant, Tennessee, became the first female patient to receive a heart transplant at Vanderbilt University Hospital. On Oct. 3, she will return to campus to participate in the Greater Nashville Heart Walk.
Sep. 10, 2015—Joshua Beckman, M.D., MSc., previously a faculty member at Harvard Medical School and Brigham and Women’s Hospital, has been named director of Vanderbilt’s newly formed Section of Vascular Medicine within the Division of Cardiovascular Medicine.
Aug. 13, 2015—A team of Vanderbilt and Nashville VA researchers, led by Adriana Hung, M.D., MPH, has been awarded a grant from the U.S. Department of Veterans Affairs to use the Million Veteran Program (MVP) data to conduct diabetes research.
Jun. 17, 2015—Vanderbilt Heart and Vascular Institute now offers patients with atrial fibrillation (AF) an alternative treatment to reduce their risk of stroke, potentially avoiding the long-term use of blood thinners such as warfarin.
May. 21, 2015—With support from a three-year, $2 million research grant from Patient-Centered Outcomes Research Institute (PCORI), Vanderbilt University Medical Center and the American Heart Association are teaming up to study heart failure care in the Emergency Department.
Apr. 9, 2015—When atherosclerosis develops in the coronary arteries over a period of time, complete blockage of that artery can result in chest pain, shortness of breath and decreased quality of life.